Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value
$2.09B
Total Bought
$705.61M
Total Sold
$461.83M
Net Transaction
+$243.79M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
AMBRX BIOPHARMA INC011,231,000+11,231,0000159,9297.66%+159,929
EYEPOINT PHARMACEUTICALS INC(EYPT)3,200,0006,038,235+2,838,23525,568139,5446.68%+113,976
RAYZEBIO INC1,182,2631,213,478+31,21526,24675,4423.61%+49,196
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)8,142,1008,494,151+352,051464,100512,96224.56%+48,862
ALX ONCOLOGY HLDGS INC(ALXO)612,0793,142,079+2,530,0002,93846,7862.24%+43,848
AUTOLUS THERAPEUTICS PLC(AUTL)392,1675,450,000+5,057,83391435,0981.68%+34,184
CARGO THERAPEUTICS INC01,182,563+1,182,563027,3761.31%+27,376
ALPINE IMMUNE SCIENCES INC1,900,0002,550,000+650,00021,75548,6032.33%+26,848
SYNDAX PHARMACEUTICALS INC(SNDX)01,175,000+1,175,000025,3921.22%+25,392
KORRO BIO INC(KRRO)0529,170+529,170025,3631.21%+25,363
ABIVAX SA(ABVX)02,130,000+2,130,000022,7911.09%+22,791
HARPOON THERAPEUTICS INC54,0602,349,060+2,295,00021822,5511.08%+22,333
SPYRE THERAPEUTICS INC(SYRE)0937,080+937,080020,1660.97%+20,166
PHARVARIS N V
COM
1,361,4601,711,460+350,00028,41448,0062.30%+19,593
ARCELLX INC
COMMON STOCK
2,150,0001,700,000-450,00077,14294,3504.52%+17,208
NEUROGENE INC(NGNE)0746,180+746,180014,4610.69%+14,461
MARINUS PHARMACEUTICALS INC2,625,0003,250,000+625,00021,13135,3281.69%+14,196
PRAXIS PRECISION MEDICINES I(PRAX)0633,345+633,345014,1110.68%+14,111
BRIDGEBIO PHARMA INC(BBIO)4,662,5303,344,179-1,318,351122,951135,0056.46%+12,054
EDGEWISE THERAPEUTICS INC(EWTX)2,946,8872,551,989-394,89816,88627,9191.34%+11,033
CRINETICS PHARMACEUTICALS IN(CRNX)1,101,9041,150,000+48,09632,77140,9171.96%+8,146
VAXCYTE INC(PCVX)665,000665,000033,90241,7622.00%+7,860
RAPT THERAPEUTICS INC325,000496,750+171,7505,40212,3440.59%+6,943
AEROVATE THERAPEUTICS INC1,561,6961,211,696-350,00021,19227,4211.31%+6,228
RHYTHM PHARMACEUTICALS INC(RYTM)850,000550,000-300,00019,48625,2841.21%+5,797
LANTHEUS HLDGS INC(LNTH)075,000+75,00004,6500.22%+4,650
ROCKET PHARMACEUTICALS INC(RCKT)450,000450,00009,22113,4870.65%+4,266
INSMED INC(INSM)575,000575,000014,51917,8190.85%+3,301
VYNE THERAPEUTICS INC(YARW)01,394,336+1,394,33603,2490.16%+3,249
BIOMEA FUSION INC(BMEA)3,570,8723,570,872049,13551,8492.48%+2,714
IMMUNOVANT INC(IMVT)1,225,0001,165,000-60,00047,02849,0812.35%+2,054
AXONICS INC250,000250,000014,03015,5580.74%+1,528
STOKE THERAPEUTICS INC(STOK)1,087,8071,087,80704,2865,7220.27%+1,436
BIOHAVEN LTD(BHVN)81,96381,96302,1323,5080.17%+1,376
LONGBOARD PHARMACEUTICALS IN2,353,1412,353,141013,08314,1890.68%+1,106
BIOATLA INC(BCAB)1,181,1151,181,11502,0082,9060.14%+898
CENTESSA PHARMACEUTICALS PLC561,600561,60003,6344,4700.21%+837
NEUMORA THERAPEUTICS INC.(NMRA)92,29392,29301,3021,5740.08%+271
VERVE THERAPEUTICS INC350,000350,00004,6414,8790.23%+238
IDEAYA BIOSCIENCES INC(IDYA)600,000450,000-150,00016,18816,0110.77%-177
ORCHARD THERAPEUTICS PLC25,6640-25,6641980—-198
IMMUNEERING CORP4,204,3644,204,364032,29030,9021.48%-1,387
TARSUS PHARMACEUTICALS INC(TARS)2,621,4222,221,422-400,00046,58344,9842.15%-1,599
GH RESEARCH PLC(GHRS)593,043593,04305,9603,4400.16%-2,520
VIGIL NEUROSCIENCE INC616,7860-616,7863,3240—-3,324
DISC MEDICINE INC(IRON)225,000125,000-100,00010,5717,2200.35%-3,350
COGENT BIOSCIENCES INC(COGT)1,000,0000-1,000,0009,7500—-9,750
AVIDITY BIOSCIENCES INC1,762,1150-1,762,11511,2420—-11,242
ZENTALIS PHARMACEUTICALS INC(ZNTL)700,0000-700,00014,0420—-14,042
CYMABAY THERAPEUTICS INC3,850,0001,800,000-2,050,00057,40442,5162.04%-14,887
PRAXIS PRECISION MEDICINES I9,500,0000-9,500,00016,2450—-16,245
ENLIVEN THERAPEUTICS INC1,216,7120-1,216,71216,6200—-16,620
OLEMA PHARMACEUTICALS INC(OLMA)4,504,7642,456,800-2,047,96455,63434,4691.65%-21,165
ERASCA INC(ERAS)10,813,2460-10,813,24621,3020—-21,302
KARUNA THERAPEUTICS INC140,0000-140,00023,6730—-23,673
APELLIS PHARMACEUTICALS INC
COM
2,000,000625,000-1,375,00076,08037,4131.79%-38,667
CABALETTA BIO INC(CABA)2,879,4240-2,879,42443,8250—-43,825
STRUCTURE THERAPEUTICS INC1,056,3730-1,056,37353,2620—-53,262
AMBRX BIOPHARMA INC9,923,6890-9,923,689114,1220—-114,122
Page 1 of 1
Cormorant Asset Management, LP — 13F Holdings — Q4 2023 | TickerTrail